Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2024-12-24 | 2024-12-24 |
| Drug Identification Number | 02046210 | 02046210 |
| Brand name | LUTREPULSE PWS 0.8MG/VIAL | LUTREPULSE PWS 0.8MG/VIAL |
| Common or Proper name | Gonadorelin Acetate | Gonadorelin Acetate |
| Company Name | FERRING INC | FERRING INC |
| Ingredients | GONADORELIN ACETATE | GONADORELIN ACETATE |
| Strength(s) | 0.8MG | 0.8MG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 10mL vial | 10mL vial |
| ATC code | H01CA | H01CA |
| ATC description | HYPOTHALAMIC HORMONES | HYPOTHALAMIC HORMONES |
| Reason for discontinuation | Manufacturing issues | Manufacturing issues |
| Anticipated discontinuation date | ||
| Actual discontinuation date | 2024-11-26 | 2024-11-26 |
| Remaining supply date | ||
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | Lutrapulse 0.8mg is no longer available worldwide beyond June 30, 2024 due to expiry dating of existing supply. No new product will be manufactured or is available due to manufacturing line decommissioning. | Lutrapulse 0.8mg is no longer available worldwide beyond June 30, 2024 due to expiry dating of existing supply. No new product will be manufactured or is available due to manufacturing line decommissioning. |
| Health Canada comments |